Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
1(6%)
Results Posted
8%(1 trials)

Phase Distribution

Ph phase_3
5
28%
Ph not_applicable
4
22%
Ph phase_4
4
22%
Ph phase_2
1
6%

Phase Distribution

0

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
5(35.7%)
Phase 4Post-market surveillance
4(28.6%)
N/ANon-phased studies
4(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

18

all time

Status Distribution
Active(2)
Completed(13)
Other(3)

Detailed Status

Completed13
unknown3
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.1%)
Phase 35 (35.7%)
Phase 44 (28.6%)
N/A4 (28.6%)

Trials by Status

not_yet_recruiting16%
completed1372%
recruiting16%
unknown317%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT03859921Phase 3

Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET

Recruiting
NCT06952296

Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain

Not Yet Recruiting
NCT05767086Not Applicable

Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles

Completed
NCT04788108Phase 4

Oral Progesterone for Prevention of Miscarriage in Threatened Abortion

Completed
NCT05972902Phase 3

Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes

Unknown
NCT05577806

DYG Versus Cetrorelix in Oocyte Donation

Completed
NCT02921763

A Survey on Efficacy and Safety in Patients With Endometriosis

Completed
NCT03935152Phase 4

Oral Dydrogesterone in the Management of Preterm Labor

Completed
NCT04287205Not Applicable

The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis

Completed
NCT03790215Phase 4

Dydrogesterone in the Treatment of Endometrial Polyps

Completed
NCT02128685Phase 3

Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage

Completed
NCT03309735

Non-interventional Study of Therapy for Threatened Miscarriage

Completed
NCT02989519Phase 3

Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor

Completed
NCT02086032Not Applicable

The Effect of Different Types of Progestin on Sleeping of Menopausal Women

Completed
NCT02990403Phase 4

The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss

Unknown
NCT02706470Phase 2

Use of Cyclosporin A for the Treatment of Recurrent Miscarriage

Unknown
NCT02262481Not Applicable

Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor

Completed
NCT00193674Phase 3

Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18